title: A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.
abstract: HLA-B27 molecules expressed on the T2 mutant cell line do not have peptides. Such empty HLA-B27 molecules were not recognized by an HLA-B27-restricted cytotoxic T-lymphocyte (CTL) clone (auto-1) derived from synovial fluid. To test for peptide dependency of the clone, B27-T2 cells were incubated with a panel of 48 different peptides. This lack of stringency was compared with that of a peptide-dependent monoclonal antibody, B27.M2. Positive B27.M2 reactivity resulted when the B27-T2 cells were incubated with two peptides: RRKAMFEDI and RRMGPPVGHR, derived from Chlamydia HSP60 and human ribonucleoprotein, respectively. Because of the limited availability of CTL versus monoclonal antibody, the specificity of B27.M2 was studied in greater detail. The importance of the HLA-B27 heavy chain in antibody recognition of class I-peptide complexes was demonstrated by site-directed mutagenesis. The stringency of the peptide residues was tested by making analogs of each of the nine residues in RRKAMFEDI, creating a panel of 180 analogs. Although stringency was highest for the sixth position, as many as six different amino acids provided positive reactivity. These results indicate that immune recognition of HLA-B27-peptide complexes might have rather low stringency for the peptide sequences. In theory, then, pathogen-derived peptides which induce autoimmunity by generating autoreactive CTL might not share much sequence similarity with the responsible self peptides.
authors.affiliation: Department of Medicine, University of California-Los Angeles 90024, USA.
authors.forename: F
authors.initials: F
authors.lastname: Huang
authors.forename: E
authors.initials: E
authors.lastname: Hermann
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.forename: X K
authors.initials: XK
authors.lastname: Cheng
authors.forename: W C
authors.initials: WC
authors.lastname: Tsai
authors.forename: J
authors.initials: J
authors.lastname: Wen
authors.forename: J G
authors.initials: JG
authors.lastname: Kuipers
authors.forename: H
authors.initials: H
authors.lastname: Kellner
authors.forename: B
authors.initials: B
authors.lastname: Ackermann
authors.forename: G
authors.initials: G
authors.lastname: Roth
authors.forename: K M
authors.initials: KM
authors.lastname: Williams
authors.forename: D K
authors.initials: DK
authors.lastname: Yu
authors.forename: R B
authors.initials: RB
authors.lastname: Raybourne
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D001483:Base Sequence; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic; D005434:Flow Cytometry; D015796:HLA-B27 Antigen / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007739:L Cells; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D009842:Oligopeptides / Q000138:chemical synthesis / Q000276:immunology*; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000276:immunology*; D014162:Transfection
chemical_list: D000911:Antibodies, Monoclonal; D015796:HLA-B27 Antigen; D009842:Oligopeptides